Tenofovir Alafenamide in Preventing Liver Complications in Participants With Current or Past Hepatitis B Virus Who Are Receiving Anti-Cancer Therapy for Solid Tumors
Conditions: Hepatitis B Virus Positive; Malignant Solid Neoplasm Interventions: Other: Best Practice; Other: Laboratory Biomarker Analysis; Drug: Tenofovir Alafenamide Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Therapy | Hepatitis | Hepatitis B | Liver | Research | Urology & Nephrology | Viread